Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.

BACKGROUND AND AIMS: To evaluate the efficacy and safety of the topical corticosteroid budesonide, given in an oral controlled release formulation for maintenance of remission in patients with ileal and ileocaecal Crohn's disease (CD). PATIENTS AND METHODS: Out of 176 patients with active CD wh...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Löfberg, R, Rutgeerts, P, Malchow, H, Lamers, C, Danielsson, A, Olaison, G, Jewell, D, Ostergaard Thomsen, O, Lorenz-Meyer, H, Goebell, H, Hodgson, H, Persson, T, Seidegård, C
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: 1996
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC1383237/
https://ncbi.nlm.nih.gov/pubmed/8881815
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Rhyngrwyd

https://ncbi.nlm.nih.gov/pmc/articles/PMC1383237/
https://ncbi.nlm.nih.gov/pubmed/8881815

Eitemau Tebyg